ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,836,789 | +282.6% | 1,795,436 | +423.0% | 0.00% | – |
| Q2 2023 | $741,506 | +596.0% | 343,290 | +576.7% | 0.00% | – |
| Q1 2023 | $106,531 | +13.8% | 50,729 | +18.7% | 0.00% | – |
| Q4 2022 | $93,594 | +67.1% | 42,737 | +127.3% | 0.00% | – |
| Q3 2022 | $56,000 | -51.3% | 18,800 | -53.7% | 0.00% | – |
| Q2 2022 | $115,000 | -90.6% | 40,600 | -82.2% | 0.00% | – |
| Q1 2022 | $1,217,000 | -32.9% | 227,521 | -6.3% | 0.00% | – |
| Q4 2021 | $1,814,000 | -53.8% | 242,694 | -43.9% | 0.00% | – |
| Q3 2021 | $3,929,000 | +1719.0% | 432,715 | +875.2% | 0.00% | – |
| Q2 2021 | $216,000 | +260.0% | 44,373 | +229.4% | 0.00% | – |
| Q1 2021 | $60,000 | +13.2% | 13,470 | +12.3% | 0.00% | – |
| Q2 2020 | $53,000 | +1.9% | 11,998 | -35.5% | 0.00% | – |
| Q1 2020 | $52,000 | -8.8% | 18,605 | +35.1% | 0.00% | – |
| Q4 2019 | $57,000 | – | 13,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |